Securities Fraud Lawsuit Filed Against Akebia Therapeutics, Inc. (AKBA)
A securities fraud lawsuit has been filed against Akebia Therapeutics, Inc. (NASDAQ: AKBA) for potential securities violations on behalf of shareholders who purchased shares anytime during the period from June 28, 2018 through September 2, 2020. The release of potentially misrepresentative and misleading information, as well as failure to disclose material adverse facts to the […]